can semaglutide damage your pancreas Suspected drug-induced pancreatitis was rare but more common in patients taking GLP-1 agonists than sulfonylureas, a recent analysis of a VA database finds New Weight-Loss Drugs Under Scrutiny
Description
During the week of June 15, 2026, FDA issued 25 warning letters to telehealth companies over alleged false or misleading promotional claims about compounded GLP-1 productsclaims the agency views as violating the Federal Food, Drug, and Cosmetic Acts (FDCA) misbranding provisions, including Sections 502(a) and 502(n).

Compounded Semaglutide & Tirzepatide delivered to your door

Get expert-backed tips on managing withdrawal symptoms and maintaining your progress.
Weve discussed the hockey-stick rise in the adoption and persistent use of GLP-1 drugs for managing diabetes and obesity here in Health Populi
